HomeALLO • NASDAQ
add
Allogene Therapeutics Inc
Previous close
$2.69
Day range
$2.71 - $2.86
Year range
$2.01 - $5.78
Market cap
593.88M USD
Avg Volume
1.91M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 16.09M | -13.16% |
Net income | -66.36M | 16.25% |
Net profit margin | — | — |
Earnings per share | -0.32 | 39.08% |
EBITDA | -62.80M | 18.33% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 444.63M | -9.62% |
Total assets | 646.88M | -16.10% |
Total liabilities | 131.84M | -10.95% |
Total equity | 515.04M | — |
Shares outstanding | 209.11M | — |
Price to book | 1.09 | — |
Return on assets | -26.94% | — |
Return on capital | -28.48% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -66.36M | 16.25% |
Cash from operations | -63.59M | -2.80% |
Cash from investing | 74.61M | 334.81% |
Cash from financing | 108.60M | 21.31% |
Net change in cash | 119.63M | 166.87% |
Free cash flow | -20.15M | 42.96% |
About
Founded
2017
Headquarters
Website
Employees
232